Navigation Links
Many options, good outcomes, for early-stage follicular lymphoma
Date:8/21/2012

A University of Rochester Medical Center study published in the Journal of Clinical Oncology, challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient is carefully examined and staged at diagnosis.

The research underlines the fact that when cancer strikes, modern patients and their oncologists across the United States are taking many diverse treatment paths when there is scant data to support one method over another. This study suggests that the old standard approach radiation therapy, alone is no longer the best choice for early follicular lymphoma, according to researchers at the James P. Wilmot Cancer Center at URMC.

Lead author Jonathan W. Friedberg, M.D., acting director of the Wilmot Cancer Center and chair of Hematology/Oncology at URMC, pointed out that the earlier recommendation for radiation was based on uncontrolled experiences at select institutions.

"As we move into an era focused on quality, we need research like this to help us determine the true effectiveness of various therapies when definitive studies are lacking," Friedberg said. "The choice of treatment should be based on whether it produces remission and survival. And if the outcomes are equivalent, then we'll need to consider toxicities and tolerance of therapies, as well as cost. We hope our data will assist physicians in making decisions with patients."

Researchers followed 471 patients for up to 10 years. The study is believed to be the largest of early-stage follicular lymphoma (FL) in the modern treatment era.

All patients were identified through a disease registry called National LymphoCare, which includes more than 2,700 cases diagnosed between 2004 and 2007, at 200 medical practices in the U.S.

As the definition of stage 1 FL changed over time, so did the way doctors evaluated and diagnosed patients. Two groups emerged in the s
'/>"/>

Contact: Leslie Orr
Leslie_Orr@urmc.rochester.edu
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study: Majority of older, early-stage breast cancer patients benefit from radiation after lumpectomy
2. Protein may represent a switch to turn off B cell lymphoma
3. Researchers make promising discovery in pursuit of effective lymphoma treatments
4. New drug strategy attacks resistant leukemia and lymphoma
5. Mutations in JAK3 gene identified in subtype of lymphoma provide potential drug target
6. Limited Radiation May Help Some Kids With Lymphoma
7. Progress in quest to reduce use of radiation in treatment of pediatric Hodgkin lymphoma
8. New drug dramatically improves survival in Hodgkin lymphoma patients
9. Moffitt Cancer Center researchers find potential key to new treatment for mantle cell lymphoma
10. New research seeks to improve survival for myeloma and lymphoma patients
11. Mayo Clinic completes first genome-wide analysis of peripheral T-cell lymphomas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Power morcellator lawsuits ( http://www.gynecaremorcellatorlawsuit.com/ ) ... of women who allegedly experienced the spread of dangerous ... According to court documents, one of the most recent ... District Court, Northern District of New York, on behalf ... a power morcellator manufactured Karl Storz Endoscopy - America ...
(Date:8/27/2014)... August 27, 2014 NC. SonaCare Medical, ... (HIFU), announced record-setting sales of 15 HIFU devices over ... surge in demand for the company’s ablation technology. ... our team has achieved over the past year, especially ... has historically been our most active sales period,” says ...
(Date:8/27/2014)... parents shapes many aspects of our lives. But in ... is set during development, but can be altered by ... of our parents and grandparents. , The epigenome consists ... that determine whether genes are expressed or silenced. , ... health, but also that it may be possible to ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Driven by ... weatherstrip is expected to grow steadily during the next ... to reach 1.381 billion meters by end-2017. Tightness is ... seals are one of the most-used parts in an ... seals stood at 995 million meters, up just under ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Dr. Winifred ... , a leader in promoting better health outcomes through ... addition of Ms. Maura Connor to the executive team ... Editor-in-Chief, Ms. Connor will be responsible for providing innovation, ... digital products and content across all markets. , ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:SonaCare Medical Announces Twelve Months Sales Results of Fifteen HIFU Devices 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 3Health News:Scientists map the 'editing marks' on fly, worm, human genomes 4Health News:Automobile Weatherstrip Sector in China Analysed in New SinoMarketInsight Research Study Published at MarketPublishers.com 2Health News:Automobile Weatherstrip Sector in China Analysed in New SinoMarketInsight Research Study Published at MarketPublishers.com 3Health News:Maura Connor Joins Hayes, Inc. as Vice President, Digital Publishing, Editor-in-Chief 2
... superimpose genetic information over the terrain of cancerous bladders ... cancer, an international research team led by scientists at ... reports online at the journal Laboratory Investigation, a member ... organs varied tissues normal, precancerous and malignant ...
... Medpace, a leading global,full-service contract research organization, ... Clinical Pharmacology, will address three,international conferences in China ... IV Conference in Beijing, at the International Workshop ... and at the International,Society for the Study of ...
... Ever traveled from,downtown Columbia, S.C., to New York City ... covered by a group of walkers,who took time to ... @ Lunch Day(SM) event held April 30 at Columbia,s ... participated in the event,co-hosted by WLTX-TV of Columbia, 384 ...
... study shows , , MONDAY, May 5 (HealthDay News) -- ... harmless colon polyps on their journey to becoming malignant ... research, published online in Cancer Cell , ... normal organs in embryos, is produced in excess during ...
... ANTONIO, May 5 With nearly 10 million,minimally-invasive ... search of alternatives to treat their wrinkles without,having ... the past 15 years, doctors used traditional CO2 ... skin. However, these lasers are,riddled with problems including ...
... McClellan to Keynote Afternoon Session on Legal, Regulatory ... personalized medicine,revolutionize healthcare in the United States?, ... at a national conference,Personalized Medicine: Promises and Challenges, ... Science (AAAS) and the Food and Drug Law,Institute ...
Cached Medicine News:Health News:Combined physical and genetic map finds cancer's 'ignition key' 2Health News:Combined physical and genetic map finds cancer's 'ignition key' 3Health News:Combined physical and genetic map finds cancer's 'ignition key' 4Health News:Combined physical and genetic map finds cancer's 'ignition key' 5Health News:Medpace Director of Clinical Pharmacology, Jim Wei, MD, PhD, Embarks on a Regulatory Policy Speaking Tour in China in May 2Health News:Walkers Cover Hundreds of Miles During S.C. BlueCross Walk @ Lunch Day Event 2Health News:New Medical Technology is Changing the Face of Wrinkle Treatment 2Health News:AAAS, FDLI Sponsor Landmark Meeting on Personalized Medicine June 20, 2008 2Health News:AAAS, FDLI Sponsor Landmark Meeting on Personalized Medicine June 20, 2008 3
(Date:8/27/2014)... BURLINGTON, Mass. , Aug. 27, 2014 ... activity that characterized the Memphis ... given way to clinical integration, with rivals Methodist Le ... their respective physician groups to coordinate patient care. In ... Cigna, which has the most health plan enrollment in ...
(Date:8/27/2014)... ResearchMoz presents this most up-to-date ... Outlook to 2020. New report, "United States Laparoscopes Market ... United States Laparoscopes market . The report provides ... and average prices (in US dollars) within market segments ... Video Laparoscopes), Robotic Surgical Systems and Rigid Tip Non-Video ...
(Date:8/27/2014)... An experimental drug designed to help regulate the blood,s iron ... of inflammation, according to results from the first human ... Blood , the Journal of the American ... a condition that occurs when red blood cells are in ... has anemia, the body does not get enough oxygen, since ...
Breaking Medicine Technology:Memphis-area Health Systems Turn Attention to Clinical Integration 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3
... 15, 2012  Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company ... cells (CSCs) and tumor bulk, today announced that Kevin ... Since serving as Chief Executive Officer of Cephalon, Inc. ... (Nasdaq: TEVA ) in October 2011, Mr. ...
... IRVINGTON, N.Y., March 15, 2012  ORTHOCON®, Inc., a ... J. Hart has been appointed Vice President of ... in-licensing and acquiring new products and technologies for ... teams.  Mr. Hart joins ORTHOCON ...
Cached Medicine Technology:Stemline Therapeutics Appoints Kevin Buchi, Former CEO of Cephalon, to Its Board of Directors 2ORTHOCON® Names David J. Hart Vice President of Business Operations 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: